申请人:Chen Ming
公开号:US20070155727A1
公开(公告)日:2007-07-05
This invention is directed to compounds of formula (I):
where r, q, R, R
2
, R
3
, R
4a
, R
4b
, R
4c
, R
5a
, R
5b
, R
5c
, R
6a
, R
6b
, R
6c
, R
7
, R
8
, R
9
and R
10
are described herein, or pharmaceutically acceptable salts, solvates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene A
4
hydrolase inhibitors and which are therefore useful in treating inflammatory disorders. Pharmaceutical compositions comprising the compounds of the invention and methods of using and preparing the compounds of the invention are also disclosed.
本发明涉及的化合物的化学式为(I):其中r、q、R、R2、R3、R4a、R4b、R4c、R5a、R5b、R5c、R6a、R6b、R6c、R7、R8、R9和R10如本文所述,或其药学上可接受的盐、溶剂化合物、多晶形、铵离子、N-氧化物或其前药;这些化合物是白三烯A4水解酶抑制剂,因此在治疗炎症性疾病方面具有用途。本发明还涉及包含所述化合物的药物组合物以及使用和制备所述化合物的方法。